Co-Diagnostics prices $7.0M registered direct offering of 12.7M shares at $0.55/share

Co-Diagnostics, Inc.

Offering consists of 12,727,272 shares of common stock or pre-funded warrants at $0.55 per share.
Pre-funded warrants have an exercise price of $0.0001 and expire when exercised in full.
Gross proceeds estimated at $7.0M before placement agent fees and expenses.
Proceeds to be used for working capital and general corporate purposes.
Maxim Group LLC is the sole placement agent; offering expected to close October 29, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.